Tower Research Capital (TRC)’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,659
| Closed | -$71K | – | 4435 |
|
|
2019
Q4 | $71K | Buy |
4,659
+3,602
| +341% | +$31.1K | 0.01% | 1136 |
|
|
2019
Q3 | $7K | Buy |
1,057
+735
| +228% | +$6.14K | ﹤0.01% | 3186 |
|
|
2019
Q2 | $3K | Sell |
322
-5,240
| -94% | -$56.4K | ﹤0.01% | 3213 |
|
|
2019
Q1 | $75K | Buy |
5,562
+5,354
| +2,574% | +$44.6K | ﹤0.01% | 1571 |
|
|
2018
Q4 | $1K | Buy |
+208
| New | +$2.28K | ﹤0.01% | 3737 |
|
|
2018
Q3 | – | Sell |
-809
| Closed | -$7K | – | 4497 |
|
|
2018
Q2 | $7K | Buy |
809
+461
| +132% | +$4.3K | ﹤0.01% | 2985 |
|
|
2018
Q1 | $3K | Sell |
348
-712
| -67% | -$15.5K | ﹤0.01% | 2903 |
|
|
2017
Q4 | $29K | Sell |
1,060
-4,909
| -82% | -$130K | ﹤0.01% | 1780 |
|
|
2017
Q3 | $161K | Buy |
5,969
+5,869
| +5,869% | +$154K | 0.01% | 933 |
|
|
2017
Q2 | $3K | Buy |
+100
| New | +$3.04K | ﹤0.01% | 2281 |
|
|
2016
Q2 | – | Sell |
-1,678
| Closed | -$35K | – | 5278 |
|
|
2016
Q1 | $35K | Buy |
+1,678
| New | +$41.2K | 0.01% | 978 |
|
|
2015
Q4 | – | Sell |
-100
| Closed | -$2K | – | 5347 |
|
|
2015
Q3 | $2K | Buy |
+100
| New | +$2.43K | ﹤0.01% | 3471 |
|
|
2015
Q2 | – | Sell |
-100
| Closed | -$2K | – | 5313 |
|
|
2015
Q1 | $2K | Sell |
100
-1,188
| -92% | -$20K | ﹤0.01% | 3883 |
|
|
2014
Q4 | $23K | Buy |
+1,288
| New | +$21.5K | ﹤0.01% | 1516 |
|
Tower Research Capital (TRC)'s DERM Position: Q1 2020 in Review
Tower Research Capital (TRC) sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 4,659 shares — an estimated $71K sold.
Tower Research Capital (TRC) first reported a position in DERM in Q4 2014 and held it in 14 quarters. The position peaked at $161K in Q3 2017. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- Tower Research Capital (TRC) reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- Tower Research Capital (TRC) sold 4,659 Dermira, Inc. shares in Q1 2020, an estimated $71K.
- Tower Research Capital (TRC) first reported a position in Dermira, Inc. in Q4 2014 and held it in 14 quarters.
- Tower Research Capital (TRC)'s Dermira, Inc. position peaked at $161K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.